Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Free Cash Flow (2021 - 2025)

P3 Health Partners' Free Cash Flow history spans 5 years, with the latest figure at -$25.5 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 55.4% year-over-year to -$25.5 million; the TTM value through Dec 2025 reached -$91.0 million, up 17.33%, while the annual FY2025 figure was -$91.2 million, 17.22% up from the prior year.
  • Free Cash Flow reached -$25.5 million in Q4 2025 per PIIIW's latest filing, down from -$15.4 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$6.8 million in Q3 2021 to a low of -$57.2 million in Q4 2024.
  • Average Free Cash Flow over 5 years is -$23.1 million, with a median of -$22.0 million recorded in 2021.
  • The largest YoY upside for Free Cash Flow was 65.89% in 2024 against a maximum downside of 265.36% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$11.6 million in 2021, then plummeted by 175.0% to -$31.9 million in 2022, then soared by 50.9% to -$15.7 million in 2023, then crashed by 265.36% to -$57.2 million in 2024, then skyrocketed by 55.4% to -$25.5 million in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Free Cash Flow are -$25.5 million (Q4 2025), -$15.4 million (Q3 2025), and -$16.6 million (Q2 2025).